Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunction

2014 ◽  
Vol 15 (14) ◽  
pp. 1791-1806 ◽  
Author(s):  
James M Stevenson ◽  
Jeffrey R Bishop
Keyword(s):  
Sexual Dysfunction ◽  
Selective Serotonin Reuptake Inhibitor ◽  
Reuptake Inhibitor ◽  
Serotonin Reuptake ◽  
Selective Serotonin ◽  
Genetic Determinants ◽  
Serotonin Reuptake Inhibitor

A Placebo-Controlled Trial of Bupropion SR as an Antidote for Selective Serotonin Reuptake Inhibitor–Induced Sexual Dysfunction

2004 ◽  
Vol 65 (1) ◽  
pp. 62-67 ◽  
Author(s):  
Anita H. Clayton ◽  
Julia K. Warnock ◽  
Susan G. Kornstein ◽  
Relana Pinkerton ◽  
Adrienne Sheldon-Keller ◽  
...  
Keyword(s):  
Sexual Dysfunction ◽  
Selective Serotonin Reuptake Inhibitor ◽  
Reuptake Inhibitor ◽  
Serotonin Reuptake ◽  
Controlled Trial ◽  
Selective Serotonin ◽  
Serotonin Reuptake Inhibitor

scholarly journals Post-SSRI sexual dysfunction & other enduring sexual dysfunctions

2019 ◽  
Vol 29 ◽  
Author(s):  
David Healy
Keyword(s):  
Sexual Dysfunction ◽  
Clinical Research ◽  
Selective Serotonin Reuptake Inhibitor ◽  
Reuptake Inhibitor ◽  
Serotonin Reuptake ◽  
Selective Serotonin ◽  
Epidemiological Methods ◽  
Sexual Dysfunctions ◽  
Serotonin Reuptake Inhibitor

Abstract Enduring sexual difficulties following treatment with selective serotonin reuptake inhibitor antidepressants have been reported to regulators since 1991, but it was only in 2006 that a formal post-SSRI sexual dysfunction syndrome was reported. The clinical, research and regulatory implications of this syndrome are considerable and researchers using epidemiological methods are well placed to map out the contours of the problem and perhaps pinpoint possible treatments.

Sign in / Sign up

Export Citation Format

Share Document